Kenneth Luckie Vandervoort, MD | |
731 Leighton Ave Ste 300, Anniston, AL 36207-5762 | |
(256) 236-4121 | |
(256) 237-5254 |
Full Name | Kenneth Luckie Vandervoort |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 42 Years |
Location | 731 Leighton Ave Ste 300, Anniston, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912996158 | NPI | - | NPPES |
000017436 | Medicaid | AL | |
051017436 | Other | AL | BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 00013298 (Alabama) | Secondary |
207X00000X | Orthopaedic Surgery | MD.13298 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northeast Alabama Regional Medical Center | Anniston, AL | Hospital |
Clay County Hospital | Ashland, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Anniston Orthopedics Associates Pa | 3870495294 | 11 |
Southern Orthopaedic Alliance Pllc | 2365800604 | 50 |
News Archive
By exploiting the full computational power of the Japanese supercomputer, K Computer, researchers from the RIKEN HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology (OIST) in Japan and Forschungszentrum J-lich in Germany have carried out the largest general neuronal network simulation to date.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac® extended release capsules.
Prilenia, a newly formed biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that Pridopidine, its lead compound, has been selected as the first of three potential new treatments to be included in the launch of the first ever platform trial in amyotrophic lateral sclerosis (ALS).
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.
› Verified 3 days ago
Entity Name | Anniston Orthopedics Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366636706 PECOS PAC ID: 3870495294 Enrollment ID: O20040124000279 |
News Archive
By exploiting the full computational power of the Japanese supercomputer, K Computer, researchers from the RIKEN HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology (OIST) in Japan and Forschungszentrum J-lich in Germany have carried out the largest general neuronal network simulation to date.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac® extended release capsules.
Prilenia, a newly formed biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that Pridopidine, its lead compound, has been selected as the first of three potential new treatments to be included in the launch of the first ever platform trial in amyotrophic lateral sclerosis (ALS).
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.
› Verified 3 days ago
Entity Name | Southern Orthopaedic Alliance Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588364228 PECOS PAC ID: 2365800604 Enrollment ID: O20230620001264 |
News Archive
By exploiting the full computational power of the Japanese supercomputer, K Computer, researchers from the RIKEN HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology (OIST) in Japan and Forschungszentrum J-lich in Germany have carried out the largest general neuronal network simulation to date.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac® extended release capsules.
Prilenia, a newly formed biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that Pridopidine, its lead compound, has been selected as the first of three potential new treatments to be included in the launch of the first ever platform trial in amyotrophic lateral sclerosis (ALS).
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kenneth Luckie Vandervoort, MD 731 Leighton Ave Ste 300, Anniston, AL 36207-5762 Ph: (256) 236-4121 | Kenneth Luckie Vandervoort, MD 731 Leighton Ave Ste 300, Anniston, AL 36207-5762 Ph: (256) 236-4121 |
News Archive
By exploiting the full computational power of the Japanese supercomputer, K Computer, researchers from the RIKEN HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology (OIST) in Japan and Forschungszentrum J-lich in Germany have carried out the largest general neuronal network simulation to date.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of once-a-day Tiazac® extended release capsules.
Prilenia, a newly formed biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, announces that Pridopidine, its lead compound, has been selected as the first of three potential new treatments to be included in the launch of the first ever platform trial in amyotrophic lateral sclerosis (ALS).
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.
› Verified 3 days ago
Duane Dickie Tippets, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
Dr. Duane Michael Tippets, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
John Richard Payne, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
Michael Roger Wiedmer, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
Gordon Townsend Hardy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave, Suite 300, Anniston, AL 36207 Phone: 256-236-4121 Fax: 256-237-5254 | |
Andrew Charles Morris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 731 Leighton Ave Ste 300, Anniston, AL 36207 Phone: 850-916-3700 | |
Dr. Morton Sumner Rickless, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 716 E 10th St, Suite B, Anniston, AL 36207 Phone: 256-238-9500 Fax: 256-238-9524 |